Ovensa
About:
Ovensa provides nanomedicine delivery platform with mucosal and brain-barrier crossing properties to generate advanced nanotherapeutics,
Website: https://ovensa.com/
Twitter/X: ovensa_inc
Top Investors: Anges Quebec, AQC Capital, Aligo Innovation
Description:
Ovensa provides nanomedicine technology platforms, which deliver targeted oral therapy with mucosal and brain-barrier crossing properties. Ovensa focuses on developing personalized treatments for cancer and neurodegenerative diseases and on preventing antibiotic resistance.
Total Funding Amount:
$1.91M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Aurora, Ontario, Canada
Founded Date:
2012-01-01
Founders:
Philippe Tremblay, Stephane Gagne
Number of Employees:
1-10
Last Funding Date:
2017-09-12
IPO Status:
Private
Industries:
© 2025 bioDAO.ai